Diagnostic criteria and treatment of Buerger's disease: A review

International Journal of Lower Extremity Wounds

Volumn 5, Issue 2, 2006, Pages 89-95

  Lazarides, M K ^a,b   Georgiadis, G S ^a   Papas, T T ^a   Nikolopoulos, E S ^a  

^a DEMOCRITUS UNIVERSITY OF THRACE   (Greece)

^b Department of Vascular Surgery ^*  (Greece)

Author keywords

Buerger's disease; Diagnostic criteria; Thromboangiitis obliterans; Vasculitis

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; CALCIUM CHANNEL BLOCKING AGENT; CYCLOPHOSPHAMIDE; ILOPROST; PROSTACYCLIN DERIVATIVE;

ARTERY BYPASS; ARTERY OCCLUSION; ATHEROSCLEROSIS; AUTOIMMUNE DISEASE; BUERGER DISEASE; CONSERVATIVE TREATMENT; DIAGNOSTIC TEST; FEMORAL ARTERY FLOW; HUMAN; ONSET AGE; PHLEBITIS; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SMOKING; TOBACCO DEPENDENCE; ULCER HEALING; WALKING;

AGE OF ONSET; BED REST; DISEASE PROGRESSION; HUMANS; PHLEBITIS; POPLITEAL ARTERY; RISK ASSESSMENT; RISK FACTORS; SMOKING; THROMBOANGIITIS OBLITERANS; VASCULITIS;

EID: 33646538796     PISSN: 15347346     EISSN: 15526941     Source Type: Journal    
DOI: 10.1177/1534734606288817     Document Type: Review

References (43)

1. Von Winiwarter F. Ueber eine eigenthumliche Form von Endarteritis und Endophlebitis mit Gangrän des Fusses. Arch Klin Chir 1878;23:202-26.
2. Buerger L. Thromboangiitis obliterans: a study of the vascular lesions leading to presenile spontaneous gangrene. Am J Med Sci 1908;136:567-80.
3. Olin JW, Shih A. Thromboangiitis obliterans (Buerger's disease). Curr Opin Rheumatol 2006;18:18-24.
4. Heper G, Kose S, Akkoc O, Amasyali B, Kilic A. Two female non-smoker Buerger's disease cases with anticardiolipin autoantibodies and a poor prognosis. Int Heart J 2005;46:563-9.
5. Lie JT. Thromboangiitis obliterans (Buerger's disease) in an elderly man after cessation of cigarette smoking - a case report. Angiology 1987;38:864-7.
6. Tanaka K. Pathology and pathogenesis of Buerger's disease. Int J Cardiol 1998;66(Suppl):237-42.
7. Eihhorn J, Sima D, Lindschau C, Turowski A, Schmidt H, Schneider W, et al. Antiendothelial cell antibodies in thromboangiitis obliterans. Am J Med Sci 1998;315:17-23.
8. Makita S, Nakamura M, Murakami H, Komoda K, Kawazoe K, Hiramori K. Impaired endothelium-dependent vasorelaxation in peripheral vasculature of patients with thromboangiitis obliterans (Buerger's disease). Circulation 1996;94(9 Suppl):211-15.
9. Shionoya S. What is Buerger's disease? World J Surg 1983;7:544-51.
10. Shionoya S. Diagnostic criteria of Buerger's disease. Int J Cardiol 1998;66(Suppl):243-5.
11. Eastcott HHG. Buerger's disease. In: Bergan JJ, Yao JST, editors. Evaluation and treatment of upper and lower extremity circulation disorders. New York: Grune & Stratton; 1984. p. 483-97.
12. Wessler S, Ming SC, Gurewich V, Freiman DG. A critical evaluation of thrombangiitis obliterans. The case against Buerger's disease. N Engl J Med 1960;262:1149.
13. Shionoya S. Buerger's disease. In: Rutherford RB, editor. Vasular surgery. 4th ed. Philadelphia: Saunders; 1995. p. 235-45.
14. Mills JL. Buerger's disease in the 21st century: diagnosis, clinical features, and therapy. Semin Vasc Surg 2003;3:179-89.
15. Lambeth JT, Yong NK. Arteriographic findings in thromboangiitis obliterans with emphasis on femoropopliteal involvement. Am J Roentgenol Radium Ther Nucl Med 1970;109:553-62.
16. Combemale P, Consort T, Denis-Thelis L, Estival JL, Dupin M, Kanitakis J. Cannabis arteritis. Br J Dermatol 2005;152:166-9.
17. Marder VJ, Mellinghoff IK. Cocaine and Buerger's disease: is there a pathogenetic association? Arch Intern Med 2000;160: 2057-60.
18. Kobayashi M, Kurose K, Kobata T, Hida K, Sakamoto S, Matsubara J. Ischemic intestinal involvement in a patient with Buerger disease: case report and literature review. J Vasc Surg 2003;38:170-4.
19. Becit N, Unlu Y, Kocak H, Ceviz M. Involvement of the coronary artery in patients with thrombangiitis obliterans, a case report. Heart Vessels 2002;16:201-3.
20. Olin JW. Thromboangiitis obliterans (Buerger's disease). In: Rutherford RB, editor. Rutherford's vascular surgery. 6th ed. Philadelphia: Elsevier-Saunders; 2005. p. 404-19.
21. Papa MZ, Rabi I, Adar R. A point scoring system for the clinical diagnosis of Buerger's disease. Eur J Vasc Endovasc Surg 1996;11:335-9.
22. Papa MZ, Adar R. A critical look at thrombangiitis obliterans (Buerger's disease). Vasc Surg 1992;5:1-21.
23. Ohta T, Ishioashi H, Hosaka M, Sugimoto I. Clinical and social consequences of Buerger disease. J Vasc Surg 2004;39:176-80.
24. Cooper L, Tse TS, Mikhail MA, McBane RD, Stanson AW, Ballman KV. Long term survival and amputation risk in thrombangiitis obliterans (Buerger's disease). JACC 2004;44:2410-11.
25. Borner C, Heidrich H. Long term follow up of trombangiitis obliterance. Vasa 1998;27:80-6.
26. Shionoya S. Buerger's disease: diagnosis and management. Cardiovasc Surg 1993;1:207-14.
27. Fiessinger JN, Schafer M. Trial of iloprost versus aspirin treatment for critical limb ischaemia of thromboangiitis obliterans. The TAO study. Lancet 1990;335(8689):555-7.
28. The TAO Study Group. Oral iloprost in the treatment of thrombangiitis obliterans (Buerger's disease). A double blind randomised placebo-control trial. Eur J Vasc Endovasc Surg 1998;15:300-7.
29. Manfredini R, Boari B, Gallerani M, LaCecilia O, Salmi R, DeToma T, et al. Tromboangiitis obliterans in a female mild smoker treated with spinal stimulation. Am J Med Sci 2004; 327:365-8.
30. Chierichetti F, Mambini S, Bagliani A, Odero A. Treatment of Buerger's disease with electrical spinal cord stimulation - review of three cases. Angiology 2002;53:341-7.
31. Pace AV, Saratzis N, Karokis D, Dalainas D, Kitas GD. Spinal cord stimulation in Buerger's disease. Ann Rheum Dis 2002;61:1114.
32. Donas KP, Schulte S, Ktenidis K, Horsch S. The role of epidural spinal cord stimulation in the treatment of Buerger's disease. J Vasc Surg 2005;41:830-6.
33. Augustinsson LE, Carlson CA, Holm J, Jivegard L. Epidural electrical stimulation in severe limb ischemia. Pain relief, increased blood flow and a possible limb-saving effect. Ann Surg 1985;202:104-10.
34. Swigris JJ, Olin JW, Mekhail NA. Implantable spinal cord stimulator to treat the ischemic manifestations of thromboangiitis obliterans (Buerger's disease). J Vasc Surg 1999;29:928-35.
35. Isner JM, Baumgartner I, Rauh G, Schainfeld R, Blair R, Manor O. Treatment of thromboangiitis obliterans (Buerger's disease) by intramuscular gene transfer of vascular endothelial growth factor: preliminary clinical results. J Vasc Surg 1998;28:946-75.
36. Saha K, Chabra N, Gulati SM. Treatment of patients with thromboangiitis obliterans with cyclophosphamide. Angiology 2001;52:399-407.
37. Inan M, Alat I, Kutlu R, Harma A, Germen B. Successful treatment of Buerger's disease with intramedullary K-wire: the results of the first 11 extremities. Eur J Vasc Endovasc Surg 2005;29:277-80.
38. Chander J, Singh L, Lai P, Jain A, Lal P, Ramteke VK. Retroperitoneoscopic lumbar sympathectomy for Buerger's disease: a novel technique. JSLS 2004;8:291-6.
39. Sayin A, Bozurt AK, Tuzun H, Vurai FS, Erdog G, Ozer M. Surgical treatment of Buerger's disease: experience with 216 patients. Cardiovasc Surg 1993;1:377-80.
40. Sasajima T, Kubo Y, Inaha M, Goh K, Azuma N. Role of infrainguinal bypass in Buerger's disease, an eighteen-year experience. Eur J Vasc Endovasc Surg 1997;13:186-92.
41. Nakajima N. The change in concept and surgical treatment on Buerger's disease, personal experience and review. Int J Cardiol 1998;66(Suppl):273-80.
42. Dilege S, Aksoy M, Kaybali M, Genc FA, Senturk M, Baktiroglu S. Vascular reconstruction in Buerger's disease: is it feasible? Surg Today 2002;32:1042-7.
43. Gonzalez-Fajardo JA, Vaquero C. Femorocrural bypass for limb salvage: real indications and results. In: Branchereau A, Jacobs M, editors. Critical limb ischemia. Armonk (NY): Futura; 1999. p. 165-81.